Clear cell adenocarcinoma of the lung and its driver mutation
Cancer Treatment Communications · 2013
DOI: 10.1016/j.ctrc.2013.04.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Treatment Communications, 2013. Verfasst von Konrad Stopsack und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Primary lung clear cell adenocarcinomas represent a very rare histologic type. Little is known about their molecular and clinical features. An asymptomatic 59-year-old female smoker was incidentally diagnosed with a solitary peripheral pulmonary nodule without evidence of lymphadenopathy. The patient underwent a surgical resection. The poorly differentiated adenocarcinoma consisted almost entirely of clear cells (pT1a, G3, R0, pN2, cM0, stage IIIA). Other primary tumors were excluded by immunohistochemistry. Molecular analyses revealed the G12D mutation in the KRAS gene. No EGFR mutation or EML4/ALK fusion gene was present. Clear cell features are sometimes observed in various histologic types of lung cancer. Adenocarcinomas entirely comprised of clear cells are very rare. Here we describe a putative driver mutation in a case of lung clear cell adenocarcinoma. This is the first description of molecular aberrations in a clear cell adenocarcinoma of the lung.
Zitieren
APA
Stopsack, K., Soltermann, A., Zimmermann, A., Weder, W., & Curioni-Fontecedro, A. (2013). Clear cell adenocarcinoma of the lung and its driver mutation. Cancer Treatment Communications. https://doi.org/10.1016/j.ctrc.2013.04.002
Vancouver
Stopsack K, Soltermann A, Zimmermann A, Weder W, Curioni-Fontecedro A. Clear cell adenocarcinoma of the lung and its driver mutation. Cancer Treatment Communications. 2013. doi:10.1016/j.ctrc.2013.04.002
BibTeX
@article{Stopsack2013,
author = {Stopsack, Konrad and Soltermann, Alex and Zimmermann, Anne-Katrin and Weder, Walter and Curioni-Fontecedro, Alessandra},
title = {Clear cell adenocarcinoma of the lung and its driver mutation},
journal = {Cancer Treatment Communications},
year = {2013},
doi = {10.1016/j.ctrc.2013.04.002}
}
EUVIMED